To contribute to the research on COVID-19, Bactiguard donates SEK 120,000 to Karolinska Institutet (KI) at Danderyd Hospital.
“We have collaborated with Karolinska Institutet at Danderyd Hospital (KI DS) since 2010, where we share lab resources to be able to test how Bactiguard’s coating technology interacts with blood. In addition, Bactiguard has actively engaged in the fight against COVID-19 and being able to contribute further was natural to us,” says Stefan Grass, Chief Medical Officer.
The donation will be used to further equip a lab at Karolinska Institutet at Danderyd Hospital, so that it facilitates research on COVID-19. The research is conducted by, among others, the researcher Charlotte Thålin at Danderyd Hospital AB, in collaboration with Karolinska Institutet and the Royal Institute of Technology (KTH), and aims to develop and evaluate a test for COVID-19, but also involves basic research on SARS-CoV-2 and COVID-19.
“Thanks to the donation from Bactiguard, we have the opportunity to increase the speed of the project. The project will give us valuable knowledge about COVID-19 and diagnosis of the disease,” says Professor Håkan Wallén, at Karolinska Institutet at Danderyd Hospital.
“For a Swedish company like Bactiguard with research, development and production in Sweden, it is extremely valuable and rewarding to have a close and good collaboration with the healthcare sector and academia in Sweden,” continues Stefan Grass, who is supported by Håkan Wallén: “We appreciate the collaboration with Bactiguard, it shows the strength of the interaction between academia and industry”.
For further information, please contact:
Stefan Grass, Chief Medical Officer, mobile: 0707-25 24 48
